ArticleIJID regions2026
Rapid scaling up of screening for Sudan virus disease in healthcare facilities during the 2022 outbreak in Uganda.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To rapidly address the 2022 Sudan virus disease (SVD) outbreak in Uganda, the Ministry of Health (MoH) and its partners initiated a multimodal infection prevention and control (IPC) strategy. We describe the strategy deployment in five high-risk districts and its effect on SVD screening capacity. Methods: The multimodal IPC strategy included rapidly distributing communication materials and IPC supplies to healthcare facilities (HCFs), training IPC mentors and supervisors, improving healthcare worker (HCW) knowledge through cascaded training and mentorship, and establishing screening at HCFs. IPC assessments focusing on screening capacity were conducted using the MoH IPC scorecard assessment tool, and changes in scores were compared across primary-, secondary-, and tertiary-level HCFs from baseline to endline. Results: IPC materials and supplies were distributed to 1135 HCFs, 296 IPC mentors were trained, and mentorship was cascaded to 3899 frontline HCWs. Of the 1135 HCFs assessed, 426 were analyzed. The mean screening capacity assessment scores increased significantly from baseline (44%) to endline (67%) in primary and secondary HCFs, especially in Health Center (HC) II (34-60%, Conclusion: The implementation of a multimodal IPC strategy rapidly enhanced the screening capacity of Uganda's primary and secondary HCFs. However, tertiary HCFs showed little improvement. This strategy can be adopted for future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.